about
Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid AngiopathyUbiquitin regulates GGA3-mediated degradation of BACE1Natural amyloid-β oligomers acutely impair the formation of a contextual fear memory in miceNeuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.Cerebral Amyloid Angiopathy-Related Inflammation: Report of a Case with Very Difficult Therapeutic Management.Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation.Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.Recurrence of Cerebral Amyloid Angiopathy-Related Inflammation: A Report of Two Cases from the iCAβ International Network.Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency.Platelets might mediate the increase of plasma glutamate in acute ischemic stroke: relevance for early neurological deterioration.Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients?Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia.Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature.Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation.Reader response: A phase 3 trial of IV immunoglobulin for Alzheimer disease.Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease.BIOMARKERS IN CEREBRAL AMYLOID ANGIOPATHY-RELATED INFLAMMATIONCholinesterase inhibitor use is associated with increased plasma levels of anti-Abeta 1–42 antibodies in Alzheimer's disease patientsIncreased Soluble APPα, Abeta 1-42, and Anti-Abeta 1-42 Antibodies in Plasma From Down Syndrome PatientsCerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosisA challenging diagnosis of reversible "vascular" dementia: Cerebral amyloid angiopathy-related inflammation
P50
Q26781451-D04921D9-6195-4AC9-A67C-D549BB07FC54Q34025306-B013DE8D-D641-4935-AAAE-34A50A7D2282Q34125360-FF96F1A8-1134-4BD9-ACD4-B43D5CC8E9EAQ34360117-3C349A25-CAF5-49D8-AB67-0D928B61A23DQ35144996-68066885-E542-48DA-8A8F-216EB20CAEFBQ36006254-DF7DACFC-5065-4C75-82E7-8425FF1632A2Q40155575-EFBE79F0-CD1D-4B10-A3F8-6C46BBF1CB60Q40239774-625B907F-7DF2-40E5-948D-8F79E371EF6BQ40506341-6015FEEB-F44E-45D1-A00F-E49D0EC55E8BQ43234264-7E3DAD32-E870-4114-9E69-92571759F588Q45949947-B7D01F60-4221-427F-954B-486E037D4784Q46624304-46946E4A-8431-46CA-B8BE-13B56593E359Q46685634-4163A082-7D34-4F4C-925A-3803D8C5C35BQ47613704-CAD2E4BB-95CA-4012-BCAA-D2A3410057E6Q48664210-5B977F8D-E89E-4BE5-B144-292B4E259C1FQ50043322-5A7EFA7D-C248-4E5A-80C0-64ACC5BE49F1Q53360095-185F3830-3E8F-4242-8ADE-23720062ADB4Q53410443-3B760347-7AF7-4486-B3A7-19F178FCCC4BQ57495721-D51AEECB-6BA1-443F-BB41-5492518651F4Q60639608-FD5C943F-DDF7-4097-A61C-90D4341757BBQ60639609-A2F2A85B-00B7-4172-9B25-B6BC0C34EC28Q60750348-826C7041-165F-4F58-BCEF-896A0AF11752Q91246839-49E12F6F-2849-434D-9298-989C80C7FFDA
P50
description
researcher, ORCID id # 0000-0002-3385-3224
@en
wetenschapper
@nl
name
Fabrizio Piazza
@ast
Fabrizio Piazza
@en
Fabrizio Piazza
@es
Fabrizio Piazza
@nl
type
label
Fabrizio Piazza
@ast
Fabrizio Piazza
@en
Fabrizio Piazza
@es
Fabrizio Piazza
@nl
prefLabel
Fabrizio Piazza
@ast
Fabrizio Piazza
@en
Fabrizio Piazza
@es
Fabrizio Piazza
@nl
P106
P1153
35180189700
P31
P496
0000-0002-3385-3224